SV

Street Verdict

Analyst Scorecard

MANIPALHOS · NSE

Manipal Health Enterprises Limited

₹702.2

+0.83% (+₹5.75)

Prev. close

₹696.45

Volume

11,61,682

Delivery %

58.8%

As of

20 Nov 2026

Price history

₹702.2-₹22.6 (-3.12%) · 3M
18 Aug 2026 → 20 Nov 2026
65070075018 Aug09 Sept06 Oct29 Oct20 Nov
Daily closes · updates after each session

Analyst sentiment

Analysts lean bullish

1 analyst stance · last 90 days · one per analyst

Trackable

1 · 1 bull / 0 neutral / 0 bear

Long-Horizon

none in range

Commentary

none in range

Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded

Bullish 100% (1)Neutral 0% (0)Bearish 0% (0)
Explore by date range →

Analyst opinions

CallAnalystInstrumentVerdictActions
Market commentary · 2 · levels, conditionals, previews, macro & hedged views — context, not graded
CallAnalystInstrumentVerdictActions

Fundamentals

About Manipal Health Enterprises Limited

Manipal Health Enterprises Limited operates hospitals in India. The company offers services, such as multi-specialty tertiary and quaternary care through its network of hospitals. Its services include accident and emergency care, cancer care, cardiology, organ transplants, obstetrics and gynaecology, neurology, nephrology, orthopaedics, proctology, rheumatology, and urology. The company also offers medical services, including robotic spine surgery, bariatric surgery, head and neck surgery, liver transplantation, dialysis, laparoscopic surgery, organ transplant, orthopaedic robotic surgery, spine care, and clinics for conditions like epilepsy, chronic pain, and diabetes. In addition, it offers home care, a woman's and childcare centre, an insurance helpdesk, and international patient services, diagnostic services, pharmacy sales, home healthcare, teleconsultations, e-pharmacy, and digital health solutions. Further, it delivers outpatient treatment, diagnostics, and advanced clinical care through its hospital network, and collaborates with foundations and NGOs to offer healharmathcare services to underserved populations. The company was formerly known as Manipal Health Enterprises Private Limited and changed its name to Manipal Health Enterprises Limited in December 2025. The company was founded in 1991 and is headquartered in Bengaluru, India.

Details

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Mr. Dilip Jose Puthiyidathu

Headquarters

Bengaluru

Employees

24,240

Key stats

Market cap

₹87,761.96 Cr

P/E ratio (TTM)

137.9

Dividend yield

0.00%

EPS (TTM)

₹4.84

Shares float

14.05 Cr

EPS · quarter ended Jun 2026

₹1.76

Financial Performance

01 · Financials

0 Cr5000 Cr10000 Cr15000 Cr₹0%2.5%5%7.5%10%FY24FY25FY26
RevenueNet incomeEBITDANet income ÷ revenue

02 · Earnings Per Share (EPS)

0246₹FY24FY25FY26

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

0%50%100%150%FY22FY23FY24FY25FY26
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr10000 Cr20000 Cr30000 Cr₹0×1×2×3×FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

Pre-FY23 not filed in verifiable form

0 Cr10000 Cr20000 Cr30000 Cr₹FY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

Pre-FY23 not filed in verifiable form

0 Cr5000 Cr10000 Cr15000 Cr₹FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY24FY25FY26
₹6,079.39 Cr₹9,263.56 Cr₹10,935.62 Cr
EBITDA
₹1,546.86 Cr₹2,455.03 Cr₹2,834.87 Cr
₹594.32 Cr₹512.96 Cr₹654.93 Cr
Diluted EPS
₹4.52₹3.9₹4.98

09 · Balance Sheet — as filed

Annual

Line itemFY26
₹20,755.47 Cr
Inventories
₹169.85 Cr
Investments
₹2,392.36 Cr
Trade receivables
₹929.76 Cr
Cash and cash equivalents
₹299.36 Cr
Bank balances other than cash and cash equivalents
₹23.86 Cr
Loans
₹4.07 Cr
Other financial assets
₹173.99 Cr
Other current assets
₹109.29 Cr
Total
₹4,102.54 Cr
₹24,864.51 Cr
₹8,426.13 Cr
₹8,798.80 Cr
Borrowings
₹9,948.80 Cr
Lease liabilities
₹2,230.41 Cr
Other financial liabilities
₹178.76 Cr
Provisions
₹63.17 Cr
Deferred tax liabilities (net)
₹282.21 Cr
Total
₹12,703.35 Cr
Borrowings
₹604.62 Cr
Lease liabilities
₹79.22 Cr
total outstanding dues of micro enterprises and small enterprises
₹61.21 Cr
total outstanding dues of creditors other than micro enterprises and small enterprises
₹1,403.35 Cr
Other financial liabilities
₹858.51 Cr
Other current liabilities
₹283.99 Cr
Provisions
₹70.88 Cr
Current tax liabilities (net)
₹58.00 L
Total
₹3,362.36 Cr
Total equity and liabilities
₹24,864.51 Cr

The company’s own captions, order and figures from its annual reports. A dash means the company printed no figure on that line that year. Each year is read from the latest annual report that carries it and was checked against the headline total shown elsewhere on this page.

All years: consolidated statements.

10 · Cash Flow Statement — as filed

Annual

Line itemFY25FY26
₹1,569.82 Cr₹2,078.44 Cr
₹-2,658.33 Cr₹-7,036.78 Cr
₹291.28 Cr₹299.36 Cr

The company’s own captions, order and figures from its annual reports. A dash means the company printed no figure on that line that year. Each year is read from the latest annual report that carries it and was checked against the headline total shown elsewhere on this page.

All years: consolidated statements.

11 · Shareholding Pattern

NSE, quarterly

Line itemAug 26
Promoter72.08%
Public27.92%
Employee trusts0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.25 L Cr₹1,769.938.85.0913.7%0.06+11.9%+3.7%
Divi's Laboratories Limited₹2.66 L Cr₹10,037.590.815.8515.3%0.00+12.3%+47.5%
Torrent Pharmaceuticals Limited₹1.79 L Cr₹4,738.579.421.3125.8%1.79+21.5%+32.5%
Laurus Labs Limited₹1.27 L Cr₹2,34894.823.9416.8%0.48+22.0%+146.2%
Apollo Hospitals Enterprise Limited₹1.23 L Cr₹8,599.558.812.9520.5%0.90+15.7%+10.1%
Zydus Lifesciences Limited₹1.19 L Cr₹1,188.126.74.4018.6%0.46+18.4%+22.3%
Lenskart Solutions Limited₹1.16 L Cr₹689.7181.413.305.6%0.35+35.4%—
Dr. Reddy's Laboratories Limited₹1.14 L Cr₹1,37440.63.0211.4%0.21+3.2%+14.5%
Cipla Limited₹1.13 L Cr₹1,40238.93.2711.3%0.02+2.1%-6.7%
Mankind Pharma Limited₹1.03 L Cr₹2,47545.96.3111.7%0.39+17.0%+3.1%
Aurobindo Pharma Limited₹98,101.93 Cr₹1,70526.62.599.2%0.21+6.4%+48.4%
Manipal Health Enterprises Limited₹87,761.96 Cr₹667.2137.910.427.8%1.53+18.0%—

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

Documents

Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.

MANIPALHOS

Manipal Health Enterprises Completes Acquisition of Kinder Women’s Hospital for INR 130 Cr

Digital Health News · 3 days ago

MANIPALHOS

Manipal Health Reports 37% Q2 Revenue Growth to ₹3,399 Crore

Multibagg AI · 6 days ago